Clinico-pathological profile of lung cancer in Uttarakhand
- PMID: 20442840
- PMCID: PMC2862510
- DOI: 10.4103/0970-2113.53229
Clinico-pathological profile of lung cancer in Uttarakhand
Abstract
Background: Lung cancer is one of the most aggressive and prevalent type of malignancy causing high morbidity and mortality. Tobacco smoking continues to be the leading cause of lung cancer worldwide. An increasing incidence of lung cancer has been observed in India.
Objective: The aim of this study was to evaluate the clinico, a pathological profile of the lung cancer in hilly state of Uttrakhand.
Materials and methods: We performed a retrospective analysis of histopathologically proven cases of bronchogenic carcinoma admitted in our hospital from January 1998 to August 2005.
Results: Our study included 203 patients with confirmed cases of lung cancer. Male to female ratio was 8.2:1. The common age group being 40-60 years, 9.86% of the patients were less than 40 years old age. Smoking was found to be the main risk factor in 81.77% patients. The most frequent symptom was cough (72.90%) followed by fever (58.12%). The most common radiological presentation was mess lesion (46.31%). The most common histopathological type was squamous cell carcinoma (SCC) (44.83%) followed by adenocarcinoma (19.78%) and small cell lung carcinoma (SCLC) (16.75%). The majority patients (73.29%) were diagnosed in the later stages of the disease (III B and IV).
Conclusion: It was found out that SCC was the most frequent histopathological form. SCLC predominates below 40 year and SCC over 60 years of age. Smoking still remains the major risk factors in pathogenesis of lung cancer.
Keywords: Lung cancer; histopathology type; smoking; squamous cell carcinoma.
Conflict of interest statement
Similar articles
-
Clinico-Pathological Profile and Haematological Abnormalities Associated with Lung Cancer in Bangalore, India.Asian Pac J Cancer Prev. 2015;16(18):8235-8. doi: 10.7314/apjcp.2015.16.18.8235. Asian Pac J Cancer Prev. 2015. PMID: 26745066
-
A clinico-epidemiological, pathological, and molecular study of lung cancer in Northwestern India.J Cancer Res Ther. 2020 Jul-Sep;16(4):771-779. doi: 10.4103/jcrt.JCRT_473_17. J Cancer Res Ther. 2020. PMID: 32930117
-
Clinico-pathological Profile of Bronchogenic Carcinoma Among Females in North India.Indian J Chest Dis Allied Sci. 2015 Jul-Sep;57(3):161-3. Indian J Chest Dis Allied Sci. 2015. PMID: 26749914
-
[Lung cancer at a university hospital: epidemiological and histological characteristics of a recent and a historical series].Arch Bronconeumol. 2005 Jun;41(6):307-12. doi: 10.1016/s1579-2129(06)60230-9. Arch Bronconeumol. 2005. PMID: 15989887 Review. Spanish.
-
Efficacy of Osimertinib in Lung Squamous Cell Carcinoma Patients with EGFR Gene Mutation-Case Report and a Literature Review.Curr Oncol. 2022 May 13;29(5):3531-3539. doi: 10.3390/curroncol29050285. Curr Oncol. 2022. PMID: 35621675 Free PMC article. Review.
Cited by
-
RS1 gene is a novel prognostic biomarker for lung adenocarcinoma.Thorac Cancer. 2022 Jun;13(12):1850-1861. doi: 10.1111/1759-7714.14471. Epub 2022 May 15. Thorac Cancer. 2022. PMID: 35569920 Free PMC article.
-
Clinicopathological Profile of Non-small Cell Lung Cancer and the Changing Trends in Its Histopathology: Experience From a Tertiary Care Cancer Center in Kashmir, India.Cureus. 2023 Jan 23;15(1):e34120. doi: 10.7759/cureus.34120. eCollection 2023 Jan. Cureus. 2023. PMID: 36843703 Free PMC article.
-
Molecular characterization of lung carcinomas: A study on diagnostic, predictive, and prognostic markers using immunohistochemical analysis at a Tertiary Care Center in Uttarakhand, India.J Carcinog. 2021 Oct 7;20:17. doi: 10.4103/jcar.jcar_14_21. eCollection 2021. J Carcinog. 2021. PMID: 34729049 Free PMC article.
-
Clinicopathological and immunohistochemical profile of non-small cell lung carcinoma in a tertiary care medical centre in South India.Lung India. 2014 Jan;31(1):23-8. doi: 10.4103/0970-2113.125889. Lung India. 2014. PMID: 24669077 Free PMC article.
-
The Diagnostic Accuracy of a Novel Scoring System Using Multi-Detector Computed Tomography to Diagnose Lung Cancer.Cureus. 2023 Mar 6;15(3):e35848. doi: 10.7759/cureus.35848. eCollection 2023 Mar. Cureus. 2023. PMID: 37033527 Free PMC article.
References
-
- Beckett WS. Epidemiology and etiology of lung cancer. Clin Chest Med. 1993;14:1–15. - PubMed
-
- Ginsberg RJ, Vokes EE, Raben A. Cancer of the lung. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and practices of oncology. Philadelphia, PA: Lippincott-Raven; 1999. pp. 849–950.
-
- Carr DT, Holoye PY, Hong WK. Bronchogenic carcinoma. In: Murray JF, Nadal JA, editors. Textbook of respiratory medicine. 2nd ed. Philadelphia: WB Saunders Company; 1994. pp. 1528–96.
-
- Rosenow EC. Symposium on intrathoracic neoplasm, Introduction. Mayo Clin Proc. 1993;68:168–9.
-
- Franklin WA. Diagnosis of lung cancer. Chest. 2000;117:80–9. (Travis WD, Colby TV, Corrin B. Histological typing of tumors of lung and pleura. In: Sobin LH, editor. World Health Organization. Classification of tumors.3rd ed. Berlin: Springer-Verlag 1999. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials